{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:31:08Z","timestamp":1749011468009,"version":"3.28.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-024-01537-5","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T06:01:39Z","timestamp":1731477699000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of survival nomograms for patients with anaplastic thyroid carcinoma: a SEER program-based study"],"prefix":"10.1007","volume":"15","author":[{"given":"Xinming","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingwu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengwan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"1537_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13044-020-00091-w","volume":"13","author":"S De Leo","year":"2020","unstructured":"De Leo S, Trevisan M, Fugazzola L. Recent advances in the management of anaplastic thyroid cancer. Thyroid Res. 2020;13:17. https:\/\/doi.org\/10.1186\/s13044-020-00091-w.","journal-title":"Thyroid Res"},{"key":"1537_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canep.2018.01.011","volume":"53","author":"GB Hvilsom","year":"2018","unstructured":"Hvilsom GB, Londero SC, Hahn CH, Schytte S, Pedersen HB, Christiansen P, et al. Anaplastic thyroid carcinoma in Denmark 1996\u20132012: a national prospective study of 219 patients. Cancer Epidemiol. 2018;53:65\u201371. https:\/\/doi.org\/10.1016\/j.canep.2018.01.011.","journal-title":"Cancer Epidemiol"},{"key":"1537_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2019-000666","volume":"5","author":"PG Casali","year":"2020","unstructured":"Casali PG, Trama A. Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU). ESMO Open. 2020;5: e000666. https:\/\/doi.org\/10.1136\/esmoopen-2019-000666.","journal-title":"ESMO Open"},{"key":"1537_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1677\/ERC-08-0154","volume":"16","author":"RC Smallridge","year":"2009","unstructured":"Smallridge RC, Marlow LA, Copland JA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer. 2009;16:17\u201344. https:\/\/doi.org\/10.1677\/ERC-08-0154.","journal-title":"Endocr Relat Cancer"},{"key":"1537_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/EJE-20-0080","volume":"183","author":"M de Ridder","year":"2020","unstructured":"de Ridder M, Nieveen van Dijkum E, Engelsman A, Kapiteijn E, Kl\u00fcmpen HJ, Rasch C. Anaplastic thyroid carcinoma: a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades. Eur J Endocrinol. 2020;183:203\u20139. https:\/\/doi.org\/10.1530\/EJE-20-0080.","journal-title":"Eur J Endocrinol"},{"key":"1537_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang B, McLeod D, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023;401:1531\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(23)00020-X.","journal-title":"Lancet"},{"key":"1537_CR7","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2019;30:1856\u201383. https:\/\/doi.org\/10.1093\/annonc\/mdz400.","journal-title":"Ann Oncol"},{"key":"1537_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000516469","volume":"10","author":"G Mauri","year":"2021","unstructured":"Mauri G, Heged\u00fcs L, Bandula S, Cazzato RL, Czarniecka A, Dudeck O, et al. European thyroid association and cardiovascular and interventional radiological society of europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions. Eur Thyroid J. 2021;10:185\u201397. https:\/\/doi.org\/10.1159\/000516469.","journal-title":"Eur Thyroid J"},{"key":"1537_CR9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","volume":"20","author":"RI Haddad","year":"2022","unstructured":"Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, et al. Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:925\u201351. https:\/\/doi.org\/10.6004\/jnccn.2022.0040.","journal-title":"J Natl Compr Canc Netw"},{"key":"1537_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.21147\/j.issn.1000-9604.2022.03.01","volume":"34","author":"Health Comission of the People\u2019s Republic of China N","year":"2022","unstructured":"Health Comission of the People\u2019s Republic of China N. National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version). Chin J Cancer Res. 2022;34:131\u201350. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2022.03.01.","journal-title":"Chin J Cancer Res"},{"key":"1537_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0302685","volume":"19","author":"K Huang","year":"2024","unstructured":"Huang K, Yuan X, Zhao P, He Y. Effect of chemotherapy on prognosis in patients with primary pancreatic signet ring cell carcinoma: a large real-world study based on machine learning. PLoS ONE. 2024;19: e0302685. https:\/\/doi.org\/10.1371\/journal.pone.0302685.","journal-title":"PLoS ONE"},{"key":"1537_CR12","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0709","author":"D Chen","year":"2024","unstructured":"Chen D, Carr G, Worden FP, Veenstra CM, Haymart MR, Banerjee M. Survival prognostication in patients with differentiated thyroid cancer and distant metastases: a SEER population-based study. Thyroid. 2024. https:\/\/doi.org\/10.1089\/thy.2023.0709.","journal-title":"Thyroid"},{"key":"1537_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1089\/thy.2022.0339","volume":"33","author":"W Dong","year":"2023","unstructured":"Dong W, Okamoto T, Ji X, Xiang J, Zhang D, Zhang P, et al. Conditional survival rate estimates for anaplastic thyroid cancer beyond the first year: an analysis of SEER data (2004\u20132019). Thyroid. 2023;33:523\u20136. https:\/\/doi.org\/10.1089\/thy.2022.0339.","journal-title":"Thyroid"},{"key":"1537_CR14","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1007\/s00432-022-04223-7","volume":"149","author":"D Oliinyk","year":"2023","unstructured":"Oliinyk D, Augustin T, Rauch J, Koehler VF, Belka C, Spitzweg C, et al. Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study. J Cancer Res Clin Oncol. 2023;149:3527\u201347. https:\/\/doi.org\/10.1007\/s00432-022-04223-7.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1537_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12882-020-01868-9","volume":"21","author":"E Katsuyama","year":"2020","unstructured":"Katsuyama E, Miyawaki Y, Sada KE, Asano Y, Hayashi K, Yamamura Y, et al. Association of explanatory histological findings and urinary protein and serum creatinine levels at renal biopsy in lupus nephritis: a cross-sectional study. BMC Nephrol. 2020;21:208. https:\/\/doi.org\/10.1186\/s12882-020-01868-9.","journal-title":"BMC Nephrol"},{"key":"1537_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1186\/s12889-017-4922-3","volume":"17","author":"S Kalantari","year":"2017","unstructured":"Kalantari S, Khalili D, Asgari S, Fahimfar N, Hadaegh F, Tohidi M, et al. Predictors of early adulthood hypertension during adolescence: a population-based cohort study. BMC Public Health. 2017;17:915. https:\/\/doi.org\/10.1186\/s12889-017-4922-3.","journal-title":"BMC Public Health"},{"key":"1537_CR17","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3389\/fonc.2020.01356","volume":"10","author":"Y Liao","year":"2020","unstructured":"Liao Y, Yin G, Fan X. The positive lymph node ratio predicts survival in T(1\u20134)N(1\u20133)M(0) non-small cell lung cancer: a nomogram using the SEER database. Front Oncol. 2020;10:1356. https:\/\/doi.org\/10.3389\/fonc.2020.01356.","journal-title":"Front Oncol"},{"key":"1537_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40618-023-02129-w","volume":"47","author":"Q Ma","year":"2024","unstructured":"Ma Q, Chen Z, Fang Y, Wei X, Wang N, Zhou X, et al. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study. J Endocrinol Invest. 2024;47:115\u201329. https:\/\/doi.org\/10.1007\/s40618-023-02129-w.","journal-title":"J Endocrinol Invest"},{"key":"1537_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12020-022-03085-w","volume":"77","author":"M Wang","year":"2022","unstructured":"Wang M, Wei T, Gong R, Zhu J, Li Z. Risk stratification in patients with anaplastic thyroid carcinoma: role of age. Endocrine. 2022;77:305\u201318. https:\/\/doi.org\/10.1007\/s12020-022-03085-w.","journal-title":"Endocrine"},{"key":"1537_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/jamaoto.2022.5045","volume":"149","author":"SS Wu","year":"2023","unstructured":"Wu SS, Lamarre ED, Yalamanchali A, Brauer PR, Hong H, Reddy CA, et al. Association of treatment strategies and tumor characteristics with overall survival among patients with anaplastic thyroid cancer: a single-institution 21-year experience. JAMA Otolaryngol Head Neck Surg. 2023;149:300\u20139. https:\/\/doi.org\/10.1001\/jamaoto.2022.5045.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1537_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/cen.14675","volume":"96","author":"X Huang","year":"2022","unstructured":"Huang X, Xia Q, Huang Y, Peng A, Yang J. Age increased the cancer-specific mortality risk of thyroid cancer with lung metastasis. Clin Endocrinol (Oxf). 2022;96:719\u201327. https:\/\/doi.org\/10.1111\/cen.14675.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1537_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.amjsurg.2020.09.025","volume":"221","author":"ZT Sahli","year":"2021","unstructured":"Sahli ZT, Canner JK, Zeiger MA, Mathur A. Association between age and disease specific mortality in medullary thyroid cancer. Am J Surg. 2021;221:478\u201384. https:\/\/doi.org\/10.1016\/j.amjsurg.2020.09.025.","journal-title":"Am J Surg"},{"key":"1537_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12902-019-0367-2","volume":"19","author":"C Gambardella","year":"2019","unstructured":"Gambardella C, Offi C, Patrone R, Clarizia G, Mauriello C, Tartaglia E, et al. Calcitonin negative medullary thyroid carcinoma: a challenging diagnosis or a medical dilemma. BMC Endocr Disord. 2019;19:45. https:\/\/doi.org\/10.1186\/s12902-019-0367-2.","journal-title":"BMC Endocr Disord"},{"key":"1537_CR24","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1038\/onc.2013.446","volume":"33","author":"T Liu","year":"2014","unstructured":"Liu T, Wang N, Cao J, Sofiadis A, Dinets A, Zedenius J, et al. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas. Oncogene. 2014;33:4978\u201384. https:\/\/doi.org\/10.1038\/onc.2013.446.","journal-title":"Oncogene"},{"key":"1537_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000375534","volume":"77","author":"J Liu","year":"2015","unstructured":"Liu J, Du J, Fan J, Liu K, Zhang B, Wang S, et al. The neutrophil-to-lymphocyte ratio correlates with age in patients with papillary thyroid carcinoma. ORL J Otorhinolaryngol Relat Spec. 2015;77:109\u201316. https:\/\/doi.org\/10.1159\/000375534.","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"1537_CR26","doi-asserted-by":"publisher","first-page":"6466","DOI":"10.3390\/ijms24076466","volume":"24","author":"C Gambardella","year":"2023","unstructured":"Gambardella C, Mongardini FM, Paolicelli M, Bentivoglio D, Cozzolino G, Ruggiero R, et al. Role of inflammatory biomarkers (NLR, LMR, PLR) in the prognostication of malignancy in indeterminate thyroid nodules. Int J Mol Sci. 2023;24:6466. https:\/\/doi.org\/10.3390\/ijms24076466.","journal-title":"Int J Mol Sci"},{"key":"1537_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.830760","volume":"13","author":"S Jin","year":"2022","unstructured":"Jin S, Liu X, Peng D, Li D, Ye YN. Differences between cancer-specific survival of patients with anaplastic and primary squamous cell thyroid carcinoma and factors influencing prognosis: a SEER database analysis. Front Endocrinol (Lausanne). 2022;13: 830760. https:\/\/doi.org\/10.3389\/fendo.2022.830760.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1537_CR28","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/pon.3480","volume":"23","author":"LP Forsythe","year":"2014","unstructured":"Forsythe LP, Alfano CM, Kent EE, Weaver KE, Bellizzi K, Arora N, et al. Social support, self-efficacy for decision-making, and follow-up care use in long-term cancer survivors. Psychooncology. 2014;23:788\u201396. https:\/\/doi.org\/10.1002\/pon.3480.","journal-title":"Psychooncology"},{"key":"1537_CR29","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1002\/cam4.778","volume":"5","author":"RL Shi","year":"2016","unstructured":"Shi RL, Qu N, Lu ZW, Liao T, Gao Y, Ji QH. The impact of marital status at diagnosis on cancer survival in patients with differentiated thyroid cancer. Cancer Med. 2016;5:2145\u201354. https:\/\/doi.org\/10.1002\/cam4.778.","journal-title":"Cancer Med"},{"key":"1537_CR30","doi-asserted-by":"publisher","first-page":"6788","DOI":"10.1245\/s10434-023-13945-y","volume":"30","author":"SP Ginzberg","year":"2023","unstructured":"Ginzberg SP, Gasior JA, Passman JE, Ballester J, Finn CB, Karakousis GC, et al. Disparities in presentation, treatment, and survival in anaplastic thyroid cancer. Ann Surg Oncol. 2023;30:6788\u201398. https:\/\/doi.org\/10.1245\/s10434-023-13945-y.","journal-title":"Ann Surg Oncol"},{"key":"1537_CR31","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1245\/s10434-023-13158-3","volume":"30","author":"SP Ginzberg","year":"2023","unstructured":"Ginzberg SP, Soegaard Ballester JM, Wirtalla CJ, Morales KH, Pryma DA, Mandel SJ, et al. Racial and ethnic disparities in appropriate thyroid cancer treatment, before and after the release of the 2015 American thyroid association guidelines. Ann Surg Oncol. 2023;30:2928\u201337. https:\/\/doi.org\/10.1245\/s10434-023-13158-3.","journal-title":"Ann Surg Oncol"},{"key":"1537_CR32","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1089\/thy.2016.0626","volume":"27","author":"SA Shah","year":"2017","unstructured":"Shah SA, Adam MA, Thomas SM, Scheri RP, Stang MT, Sosa JA, et al. Racial disparities in differentiated thyroid cancer: have we bridged the gap. Thyroid. 2017;27:762\u201372. https:\/\/doi.org\/10.1089\/thy.2016.0626.","journal-title":"Thyroid"},{"key":"1537_CR33","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.surg.2021.05.001","volume":"170","author":"PK Crepeau","year":"2021","unstructured":"Crepeau PK, Kulkarni K, Martucci J, Lai V. Comparing surgical thoroughness and recurrence in thyroid cancer patients across race\/ethnicity. Surgery. 2021;170:1099\u2013104. https:\/\/doi.org\/10.1016\/j.surg.2021.05.001.","journal-title":"Surgery"},{"key":"1537_CR34","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1089\/thy.2023.0164","volume":"33","author":"A Jannin","year":"2023","unstructured":"Jannin A, Giudici F, de la Fouchardi\u00e8re C, Al Ghuzlan A, Wassermann J, Chougnet CN, et al. Factors associated with survival in anaplastic thyroid carcinoma: a multicenter study from the ENDOCAN-TUTHYREF network. Thyroid. 2023;33:1190\u2013200. https:\/\/doi.org\/10.1089\/thy.2023.0164.","journal-title":"Thyroid"},{"key":"1537_CR35","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1038\/s41598-023-30162-5","volume":"13","author":"S Cho","year":"2023","unstructured":"Cho S, Kim H, Oh YL, Hahn SY, Kim TH, Shin JH. Comparison of clinicopathological characteristics and survival between symptomatic and asymptomatic anaplastic thyroid carcinoma. Sci Rep. 2023;13:3264. https:\/\/doi.org\/10.1038\/s41598-023-30162-5.","journal-title":"Sci Rep"},{"key":"1537_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13014-023-02249-w","volume":"18","author":"J Jacob","year":"2023","unstructured":"Jacob J, Vordermark D, Lorenz K, Medenwald D. Prognostic factors in radiotherapy of anaplastic thyroid carcinoma: a single center study over 31 years. Radiat Oncol. 2023;18:71. https:\/\/doi.org\/10.1186\/s13014-023-02249-w.","journal-title":"Radiat Oncol"},{"key":"1537_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1210\/jc.2016-2555","volume":"102","author":"V Marotta","year":"2017","unstructured":"Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, et al. Germline polymorphisms of the VEGF pathway predict recurrence in nonadvanced differentiated thyroid cancer. J Clin Endocrinol Metab. 2017;102:661\u201371. https:\/\/doi.org\/10.1210\/jc.2016-2555.","journal-title":"J Clin Endocrinol Metab"},{"key":"1537_CR38","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1210\/jc.2017-01180","volume":"102","author":"N Prasongsook","year":"2017","unstructured":"Prasongsook N, Kumar A, Chintakuntlawar AV, Foote RL, Kasperbauer J, Molina J, et al. Survival in response to multimodal therapy in anaplastic thyroid cancer. J Clin Endocrinol Metab. 2017;102:4506\u201314. https:\/\/doi.org\/10.1210\/jc.2017-01180.","journal-title":"J Clin Endocrinol Metab"},{"key":"1537_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1089\/thy.2022.0504","volume":"33","author":"X Zhao","year":"2023","unstructured":"Zhao X, Wang JR, Dadu R, Busaidy NL, Xu L, Learned KO, et al. Surgery after BRAF-directed therapy is associated with improved survival in BRAF(V600E) mutant anaplastic thyroid cancer: a single-center retrospective cohort study. Thyroid. 2023;33:484\u201391. https:\/\/doi.org\/10.1089\/thy.2022.0504.","journal-title":"Thyroid"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-024-01537-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T06:14:53Z","timestamp":1731478493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-024-01537-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1537"],"URL":"https:\/\/doi.org\/10.1007\/s12672-024-01537-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data used in this study came from publicly available databases, so this study received an exemption from the Ethics Committee of the Affiliated Mianyang Hospital of Chengdu University of Traditional Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"650"}}